Making sense of the evidence from the age-related eye disease study 2 randomized clinical trial-reply

Affiliations

¹ Clinical Trials Branch, Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
² The EMMES Corp, Rockville, Maryland.

Comment

Emily Y Chew et al. JAMA Ophthalmol. 2014 Aug.

. 2014 Aug;132(8):1031-2.

doi: 10.1001/jamaophthalmol.2014.2009.

¹ Clinical Trials Branch, Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
² The EMMES Corp, Rockville, Maryland.

No abstract available

Comment on

Evidence for including lutein and zeaxanthin in oral supplements for age-related macular degeneration.
Musch DC. Musch DC. JAMA Ophthalmol. 2014 Feb;132(2):139-41. doi: 10.1001/jamaophthalmol.2013.7443. JAMA Ophthalmol. 2014. PMID: 24309835 No abstract available.
Making sense of the evidence from the age-related eye disease study 2 randomized clinical trial.
Downie LE, Keller PR. Downie LE, et al. JAMA Ophthalmol. 2014 Aug;132(8):1031. doi: 10.1001/jamaophthalmol.2014.2007. JAMA Ophthalmol. 2014. PMID: 25124957 No abstract available.